Structural Optimization of a Pyridinylimidazole Scaffold: Shifting the Selectivity from p38α Mitogen-Activated Protein Kinase to c‑Jun N‑Terminal Kinase 3

Similar Items

• Design, Synthesis and Biological Evaluation of 7-Chloro-9<i>H</i>-pyrimido[4,5-<i>b</i>]indole-based Glycogen Synthase Kinase-3β Inhibitors
  by: Stanislav Andreev, et al.
  Published: (2019-06-01)
• <i>N</i>¹-{4-[2-(Methylthio)-1<i>H</i>-imidazol-5-yl]pyridin-2-yl}benzene-1,4-diamine
  by: Ahmed El-Gokha, et al.
  Published: (2019-02-01)
• c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) are involved in Mycobacterium tuberculosis-induced expression of Leukotactin-1
  by: Jang-Eun Cho1, Sangjung Park2, Sang-Nae Cho3, Hyeyoung Lee2 & Yoon Suk Kim2,*
  Published: (2012-10-01)
• P38 mitogen-activated protein kinase and Parkinson’s disease
  by: He Jianying, et al.
  Published: (2018-11-01)
• Activation of p38 Mitogen-Activated Protein Kinase in Gaucher's Disease.
  by: Kazuyuki Kitatani, et al.
  Published: (2015-01-01)